EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Herbal medicines modulate gut microbiota in metabolic diseases: a review

Xin Lan, Yuankui Wei, Yuanyu Zhao, Yong Lai

Frontiers in Microbiology · 25.06.2026 · 17

DOI: 10.3389/fmicb.2026.1833443 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 25.06.2026. Verfasst von Xin Lan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Chengdu Integrated TCM and Western Medicine Hospital, Chengdu, Sichuan, China. Die Arbeit nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic diseases—including obesity, type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD)—affect over 1 billion individuals globally and are characterized by insulin resistance, chronic inflammation, and gut microbiota dysbiosis. Herbal medicines offer multi-component therapeutic potential through microbiota modulation, but mechanistic insights remain fragmented.

Objective

This review synthesizes recent advances in herbal medicine-mediated gut microbiota regulation in metabolic diseases and delineates underlying molecular mechanisms.

Methods

A comprehensive literature search was conducted across PubMed and Web of Science. Search strategies employed MeSH terms and free-text keywords encompassing herbal medicines, gut microbiota, and metabolic diseases. Two authors performed study selection and data extraction. Evidence synthesis was structured according to intervention type and metabolic disease category.

Results

Herbal polysaccharides and other compounds consistently increased beneficial bacteria and promoted short-chain fatty acids (SCFAs) production, improving intestinal barrier integrity via ZO-1/Occludin upregulation and attenuating TLR4/NF-κB-mediated inflammation. Herbal formulations exerted synergistic effects by remodeling microbial community structure, correcting SCFA/bile acid imbalances, and activating IRS1/PI3K/AKT insulin signaling. Notably, Lactobacillus and Akkermansia emerged as recurrent beneficial targets across multiple herbal interventions. However, evidence is predominantly preclinical, and translational validity to humans requires further validation.

Conclusion

Herbal medicines ameliorate metabolic diseases through multi-target gut microbiota modulation, involving SCFA production, bile acid metabolism, and inflammatory pathway attenuation. These mechanistic insights support the development of microbiota-targeted herbal therapeutics, though clinical translation necessitates standardized formulations and rigorous human trials.

Schlagwörter

Stichwörter der Autor:innen

bile acidsdysbiosisinsulin resistanceshort-chain fatty acidtraditional Chinese medicine

Autor:innen und Institutionen

  • Department of Pathology, Chengdu Integrated TCM and Western Medicine Hospital, Chengdu, Sichuan, China.
  • Institute of Traditional, Chinese Medicine of Sichuan Academy of Chinese Medicine Sciences, Chengdu, Sichuan, China.
  • Institute of Laboratory Animal Sciences, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.

Zitieren

APA

Lan, X., Wei, Y., Zhao, Y., & Lai, Y. (2026). Herbal medicines modulate gut microbiota in metabolic diseases: a review. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1833443

Vancouver

Lan X, Wei Y, Zhao Y, Lai Y. Herbal medicines modulate gut microbiota in metabolic diseases: a review. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1833443

BibTeX
@article{Lan2026,
  author = {Lan, Xin and Wei, Yuankui and Zhao, Yuanyu and Lai, Yong},
  title = {Herbal medicines modulate gut microbiota in metabolic diseases: a review},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fmicb.2026.1833443}
}
Kostenlos starten →